AVRT and WPW Syndrome
- Home
- AVRT and WPW Syndrome
AVRT and WPW Syndrome – Accessory Pathway-Mediated Palpitations
What is AVRT?
AVRT (Atrioventricular Reciprocating Tachycardia) is a rapid heart rhythm disorder caused by an abnormal electrical pathway — medically known as an “accessory pathway” — that is present congenitally between the atria and the ventricles of the heart. It is the second most common type of supraventricular tachycardia after AVNRT and typically occurs in young and healthy individuals.
Normally, there is only a single electrical bridge between the atria and the ventricles of the heart: the AV node. This bridge conducts electricity in a controlled manner, ensuring the regular functioning of the heart. However, in patients with AVRT, a second hidden pathway exists alongside the AV node. This extra pathway sets the stage for electrical signals to circulate within the heart, creating a re-entry loop.

What is an Accessory Pathway?
An accessory pathway is an abnormal muscular bridge between the atria and the ventricles. This connection, which normally should disappear during embryonic development, persists in some individuals and can cause problems throughout their lives. The vast majority of accessory pathways are located on the left side of the heart; however, they can also be found on the right side, in the anterior or posterior region.
Accessory pathways can conduct in two different ways:
Two-way conduction (manifest accessory pathway): It can conduct electricity both from the atrium to the ventricle (anterograde) and from the ventricle to the atrium (retrograde). In this case, characteristic changes appear on a standard ECG, which is called WPW syndrome.
One-way conduction (concealed accessory pathway): It conducts electricity only from the ventricle to the atrium. It leaves no trace on the ECG, which is why it is called “concealed.” In these patients, the diagnosis is usually made during an electrophysiological study.

What is WPW Syndrome?
WPW (Wolff-Parkinson-White) Syndrome is a clinical condition defined by the presence of a two-way conducting accessory pathway. Derived from the initials of the surnames of the three cardiologists who first described this syndrome in the 1930s, this name has become one of the best-known syndromes in cardiology today.
In WPW, the accessory pathway “bypasses” the AV node and transmits electricity directly to the ventricles. This condition leads to three characteristic findings on the ECG:
Delta wave: A slow and slurred upstroke seen at the beginning of the QRS complex. It is a sign that the accessory pathway reaches the ventricle early.
Short PR interval: The conduction time between the atrium and the ventricle being shorter than normal.
Wide QRS: The widening of the QRS complex due to the stimulation of the ventricles via the abnormal pathway.
If these ECG findings are accompanied by palpitation attacks, a diagnosis of WPW Syndrome is made. If there are only ECG findings and no symptoms, this is called WPW Pattern.
How Does AVRT Occur?
In AVRT, the electrical signal enters a loop between the AV node and the accessory pathway. This loop can form in two different directions:
Orthodromic AVRT: This is the most common type. Electricity travels down from the AV node to the ventricles, returns from there to the atria via the accessory pathway, and this loop continues. Narrow QRS complexes are seen on the ECG; therefore, diagnosis can be more difficult.
Antidromic AVRT: This is rarer and potentially more dangerous. Electricity travels down from the accessory pathway to the ventricles and returns to the atria through the AV node. Wide QRS complexes are seen on the ECG and can be confused with ventricular tachycardia.

Is the Risk of Sudden Death in WPW Real?
This is the question that patients and their families wonder about the most and often fear the most. Let us state it clearly first: The risk of sudden cardiac death is low for the vast majority of patients with WPW. However, this risk is not zero and should not be ignored.
The risk of sudden death increases in cases where WPW coexists with another rhythm disorder called atrial fibrillation. In atrial fibrillation, the atria generate very rapid and irregular electrical signals. These signals cannot pass through the AV node; however, some accessory pathways can filter these rapid signals and transmit them to the ventricles. This can lead to extremely rapid and dangerous contractions of the ventricles, or even ventricular fibrillation.
In the general population, the risk of sudden death due to WPW is reported to be quite low, at about 1–2 per 100,000 per year. However, this risk is much higher in patients with a high-risk accessory pathway. For this reason, it is extremely important that every patient diagnosed with WPW undergoes an electrophysiological risk evaluation.
What Are the Symptoms?
The symptoms of AVRT and WPW are largely similar to those of AVNRT:
Rapid palpitations that start and end abruptly are the primary symptom. Patients usually feel this heartbeat, ranging from 150 to 250 beats per minute, very clearly and can tell exactly when it started. Associated shortness of breath, chest tightness, dizziness, and extreme fatigue are also common. In some patients, especially if the rapid rhythm lasts long, fainting or a feeling of fainting may develop.
In patients with WPW, additional severe conditions such as palpitations occurring during exertion, sudden severe shortness of breath, or loss of consciousness during palpitations may also be observed. These findings may indicate the presence of a high-risk accessory pathway and require immediate evaluation.

Who Is Affected?
WPW and AVRT can be seen at any age and in both sexes. The prevalence of WPW in the general population is approximately 1 to 3 per 1,000. It is slightly more common in men compared to women. The vast majority of cases develop in isolation, meaning without other heart disease; however, it can also be associated with certain congenital heart diseases such as Ebstein’s anomaly.
The risk increases in those with a family history of WPW. Familial forms of WPW exist, although rare.
How Is It Diagnosed?
ECG: It is the most important diagnostic tool for WPW. The triad of delta wave, short PR interval, and wide QRS is easily noticed by an experienced eye. However, in concealed accessory pathways, the ECG may appear completely normal.
Holter monitor and long-term recording: Long-term recording supports the diagnosis in patients whose ECG appears normal outside of an attack or who show intermittent delta waves.
Exercise stress test: It may be performed in some patients to evaluate the conduction properties of the accessory pathway during exercise.
Electrophysiological Study (EPS): It is the gold standard. It determines the exact location of the accessory pathway, the conduction velocity, and most importantly, the refractory period, meaning how fast it can conduct at maximum. This information is critical in assessing the risk of sudden death. Ablation can also be performed during the same session.
What Are the Treatment Options?
Medication Therapy
Certain antiarrhythmic drugs can be used to reduce the frequency and severity of attacks. However, it should be kept in mind that in WPW, certain medications — especially digitalis and calcium channel blockers — can accelerate conduction through the accessory pathway and trigger dangerous rhythm disorders. Therefore, the choice of medication must be made by an electrophysiology specialist. Drug therapy does not offer a permanent solution and is not preferred in the long term.
Catheter Ablation – A Permanent and Definitive Solution
Catheter ablation is the gold standard in the treatment of WPW and AVRT. During the procedure, the exact location of the accessory pathway is identified using three-dimensional mapping systems combined with an electrophysiological study. Then, this abnormal pathway is permanently deactivated using radiofrequency energy (heat) or cryoenergy (cold).
When ablation is successful, the accessory pathway disappears completely; WPW ECG findings normalize, palpitation attacks stop, and most importantly, the risk of sudden death is eliminated.
WPW ablation performed under three-dimensional mapping guidance represents the pinnacle of modern electrophysiology. Thanks to real-time anatomical and electrical guidance, the procedure has become both safer and more successful. In experienced hands, a permanent success rate of over 95 percent is achieved with this method; patients can return to their daily lives in a short time, healthy and without restrictions.
Success Rates
AVRT and WPW ablation are among the most successful procedures in the field of electrophysiology. The acute success rate ranges between 95 and 98 percent. In long-term follow-ups, the rhythm disorder does not return in 90 to 95 percent of patients. The recurrence rate is between 2 and 10 percent, and this rate largely depends on the location of the accessory pathway. While success rates are higher for accessory pathways on the left side of the heart, pathways located in the septal region can be technically more challenging.
Risks and Complications
AVRT ablation is a very safe procedure in experienced centers. The rate of serious complications is less than one percent.
Mild and temporary complications include bruising or swelling in the groin area, short-term chest discomfort after the procedure, and a temporary sensation of palpitations; these resolve spontaneously within a few days.
Rare but serious complications include, most notably, the risk of damaging the AV node during the ablation of accessory pathways in the septal region. Although very rare, this condition can lead to an AV block requiring a permanent pacemaker. In addition, vascular injury, fluid accumulation around the heart (tamponade), and the risk of systemic embolism in left-sided procedures have been reported at very low rates.
The exact location of the accessory pathway within the heart directly affects both the success rate and the risk profile. Therefore, a detailed electrophysiological evaluation prior to the procedure is of great importance.
Life After Ablation
Following a successful ablation, patients are usually discharged on the same day or the following morning. They return to their daily lives within two to three days. They are advised to avoid heavy physical activity for the first week. The disappearance of the delta wave on the ECG taken after ablation in patients with WPW ECG findings is the most important indicator that the procedure was successful. The vast majority of patients are able to discontinue all antiarrhythmic medications and freely resume all kinds of activities, including sports, without any restrictions.
Special Status in Athletes with WPW
Risk assessment holds special importance in athletes diagnosed with WPW. High-intensity exercise can both trigger palpitation attacks and increase the risk of atrial fibrillation. Therefore, many international cardiology guidelines consider ablation a necessity in symptomatic WPW athletes and recommend ablation in asymptomatic athletes with high-risk accessory pathways. If ablation is successful, the athlete can return to full activity shortly.
Conclusion
WPW and AVRT are rhythm disorders that can be successfully treated with accurate diagnosis and treatment. It is of great importance to recognize this condition early, which can have serious consequences especially in young people and athletes, and to have it evaluated by a specialist. Accessory pathway ablation both eliminates palpitation attacks and completely removes the risk of sudden death, if any. Thanks to this procedure, patients get the opportunity to permanently rid themselves of this electrical burden they have carried for years.
This content is intended for general informational purposes only. Diagnostic and treatment decisions must be individually evaluated by a specialist cardiologist.